Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

Carbios Stock Jumps 5.78% Against a Lackluster CAC 40

The share of the Clermont-Ferrand based biotech company specializing in enzymatic plastic recycling shows a sharp rebound this Thursday, moving against a stable CAC 40 session (-0.06%). The price is set at 8.79 euros, up by 5.78% compared to the previous day's close, extending a positive weekly momentum of over 7%.


Carbios Stock Jumps 5.78% Against a Lackluster CAC 40

Today's Rebound Follows a Challenging Quarter

Today's rebound comes after a difficult quarter for Carbios, during which the stock lost more than 21% over three months. The stock is currently trading below its 50-day moving average, located at 9.63 euros, indicating a still fragile underlying trend. However, today's session allowed the price to clearly cross its 20-day moving average, positioned at 8.37 euros. This short-term bullish crossover constitutes an initial signal of technical recovery. The RSI, a momentum indicator, is at 34, a level close to the oversold zone suggesting that the selling pressure of recent weeks might ease. Within the Bollinger Bands, the price is in the upper part of the band, at 69% of the range between the lower bound (7.25 euros) and the upper bound (9.49 euros), marking a significant distance from the technical support identified at 7.55 euros. The resistance to watch is at 10.37 euros.

Maintains Notable Annual Performance

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Over a broader horizon, the stock maintains a notable annual performance of nearly 40%, reflecting the interest generated by the company's enzymatic depolymerization technology. The upcoming financial calendar offers two key dates that could provide new insights: the general assembly scheduled for June 18, 2026, and the publication of the 2026 half-year results on September 24. With a beta of -0.04, the stock shows almost total decorrelation with the Paris market, a common characteristic of growth stocks in the biotechnological segment, whose evolution is more linked to specific catalysts — industrial advancements, partnerships, or funding — than to general market index fluctuations. The monthly volatility remains high, at 22.66%, illustrating the magnitude of movements that can affect this moderately sized capitalization. The European context remains generally stable this Thursday, with the DAX slightly down by 0.07% in session and the SBF 120 losing 0.11%.

Related


Sector Produits Chimiques Produits Chimiques Spécialisés


Assurance vie

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit